Cadila Healthcare Sept qtr PAT seen up 11% at Rs 190 cr
Dolat Capital has come out with its earning estimates on Pharma sector for the quarter ended September 2011. According to the research firm, Cadila Healthcare September quarter net sales are expected to go up by 13.1% at Rs 1262.5 crore, year-on-year, (YoY) basis.